Leukemia

Top Story

Ibrutinib, nivolumab combination may provide new option in non-Hodgkin lymphoma subtypes

Ibrutinib, nivolumab combination may provide new option in non-Hodgkin lymphoma subtypes
January 22, 2018
In the Journals Plus

Blood cancer precursor increases cancer risk, decreases life expectancy

January 18, 2018
Patients with monoclonal gammopathy of undetermined significance had a risk for progressing to multiple myeloma or another plasma-cell or lymphoid disorder, according to…

First-line Keytruda plus chemotherapy improves OS, PFS in non-small cell lung cancer

January 16, 2018
The addition of pembrolizumab to pemetrexed and cisplatin or carboplatin improved OS and PFS as first-line treatment for patients with metastatic nonsquamous non-small…
FDA News

FDA approves Trisenox plus tretinoin as first-line therapy for acute promyelocytic leukemia

January 16, 2018
The FDA approved arsenic trioxide injection in combination with tretinoin for the treatment of patients with newly diagnosed low-risk acute promyelocytic leukemia and…
More Headlines »
CME ABIM MOC

Ace the Case: A 54-Year-Old Man With Intermittent, Painless Hematuria for the Past 4 Weeks

There is no commercial support for this activity.

This “Ace the Case” study will discuss the treatment of a 54-year-old man who presents with intermittent…
More »
Video
Meeting News Coverage

VIDEO: Data give ‘pause’ about widespread use of CAR T-cell therapy for ALL

January 4, 2017
More »
Resource Centers
San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium

CME CPE

Addressing Common Patient Concerns Regarding Biosimilars

This activity is supported by an educational grant from Pfizer, Inc.

As more biosimilars are approved for use in the United States, greater emphasis is needed on educating patients about…
More »